search.noResults

search.searching

note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
REGULATIONS 13


The safety assessment of cosmetic products


 Helena Eixarch, David Andrew – TSG Consulting, UK


Article 3 of EU Regulation 1223/2009 on cosmetic products (‘the Regulation’)1


states


that: “a cosmetic product made available on the market shall be safe for human health when used under normal or reasonably foreseeable conditions of use”. As stated in Article 10 of the Regulation, in order to ensure compliance with Article 3, the Responsible Person (RP) must, before placing the product on the market, ensure that it has “undergone a safety assessment on the basis of the relevant information and that a cosmetic product safety report is set up in accordance with Annex I”.


The Cosmetic Product Safety Report (CPSR) – Part A The structure and contents of the CPSR are described in Annex I of the Regulation. Part A of the CPSR contains the minimum information on the cosmetic product that must be used to support the safety assessment conclusion given in Part B. Very importantly, in addition to this minimum information, the safety assessor may use any additional relevant data. On the other hand, if any of the minimum information is not considered necessary (e.g. considering the product type), the absence of these data must be clearly justified.


The CPSR Part A


requirements as described in Annex I of the Regulation and its Guidelines2


are discussed in the sections below.


General information on the cosmetic product (composition and specifications)


The CPSR must include qualitative information on the cosmetic product including the chemical identity of the raw materials it contains, Note 1


their


molecular formula, INCI name and intended function. The identity of the raw material suppliers may also be considered.


April 2018


Microbiological quality The acceptable microbiological specifications of both the raw materials and the finished cosmetic product must be determined and discussed in the CPSR. As specifically stated in the Regulation: “particular attention shall be paid to cosmetics used around the eyes, on mucous membranes in general, on damaged skin, on children under three years of age, on elderly people and persons showing


PERSONAL CARE EUROPE


The quantitative composition of the product (i.e. the exact concentration of each raw material and individual ingredient) must also be indicated. Concentration ranges should not be used, but if this is unavoidable, the highest concentration should be used as a worst case for toxicological considerations. All substances intentionally added to the product must be listed, including those added indirectly (e.g. substances preserving raw materials). Compliance with any restrictions on


ingredient concentration as stated in Annexes II to VI of the Regulation should be checked at this stage. The physical and chemical


characteristics, both of the substances and the finished cosmetic product must also be taken into account. The SCCS Notes of Guidance3


describe the basic and minimum


properties to be considered for individual chemically well-defined cosmetic ingredients (e.g. molecular weight, solubility or purity) as well as for complex ingredients like mixtures of mineral, botanical, animal or biotechnological origin


(e.g. details of the preparation process or microbiological quality).


If a perfuming or flavouring substance is used, the name, code number and the identity of the supplier must be provided and the presence of any regulated substances (e.g. allergens) must be identified.


Stability of the cosmetic product A safe cosmetic product is expected to be stable under reasonably foreseeable storage conditions, as well as during transport and handling. Exposure to changing temperature, humidity, UV light or mechanical stress could affect the properties of the product, consequently reducing quality and affecting consumer safety. Relevant stability tests, adapted to the cosmetic product type, should be carried out. Stability tests can detect pH changes, colour or odour variations, phase separations or precipitation of substances, among other issues. The results of a stability test can provide useful information for the estimation of the product’s expiry date and ‘Period After Opening’ (PAO), which must be justified in the CPSR. Additionally, these results can reveal the need of specific storage or usage conditions for the product which, importantly, must be then communicated to the end users through the product label (e.g. “do not expose to heat” or “shake well before use”). This will contribute to improve the product’s performance and safety.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184